Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SPR720 versus placebo for Nontuberculous Mycobacterial Pulmonary Disease, including MAC pulmonary disease, assessing efficacy, safety, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Pulmonary Disease
• Nontuberculous Mycobacterial Pulmonary Disease

Drugs mentioned

• SPR720 (SPR720)

Snippet

Sponsor: Spero Therapeutics | Conditions: Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | Phase 2 | Status: COMPLETED